ITCM is a global manufacturer and leading innovator in customised machinery and systems for pharmaceutical packaging and processing.

 

Time is of the essence in fertility testing and Randox biochips provide rapid and accurate diagnosis of disorders associated with the reproductive system. The fertility biochip array allows simultaneous quantitative measurement of six fertility hormones from a single patient sample.

Randox fertility array analyses hormones that regulate the reproductive cycle and are used to test for various associated conditions including infertility as well as non reproductive disorders such as cancer. The array includes estradiol which is involved in the growth of the female reproductive organs and menstruation. Estradiol is used to determine the cause of amenorrhea and to diagnose precocious puberty and gynecomastia.

Randox unique biochip array technology is a revolution in diagnostic testing. The method is based on ELISA principles and with as little as 75µl of serum, all six parameters can be analysed at once. Analytes include; FSH, LH, prolactin, progesterone, testosterone and estradiol. Simultaneous analysis of six fertility hormones provides a comprehensive patient fertility profile removing the need for expensive additional analyte testing.

Randox have developed the fully automated Evidence and the semi-automated Evidence Investigator systems for analysis of biochip arrays generating up to 378 fertility tests results per hour. Implementation of these systems will provide your laboratory with significant reductions in time and labour costs.

Invest in this innovative fertility biochip array today for a cost effective and efficient solution that will provide both the clinician and patient with confidence in results.